Translational Drug Development (TD2)
Scottsdale, AZ, USA Specialty Founded 2003 51-200 employees
Oncology-focused CRO founded on the Mayo Clinic campus offering preclinical-to-clinical oncology development with PDX models, flow cytometry, and Phase I/II trial management.
Services
DISCOVERY
PRECLINICAL
ANALYTICAL
REGULATORY
Therapeutic Areas
Model Organisms
MouseRat
Certifications
Regulatory Experience
FDA